Crown Bioscience Expands Partnership with NRCMM

Crown Bioscience, a US-China preclinical CRO, has extended its partnership with the National Resource Center for Mutant Mice (NRCMM) to build experimental immune-oncology mouse models of along with models for diabetes and inflammation.  NRCMM was established by the US National Institute of Health and has a China commercial branch, the Nanjing Biotech Innovation Corporation. Crown Bioscience is headquartered in California with labs in Beijing, Taicang, the UK and North Carolina. More details.... Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.